Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

The retention and cellular internalization of drug delivery systems and theranostics for cancer therapy can be improved by targeting molecules. Since an increased uptake of riboflavin was reported for various cancers, riboflavin and its derivatives may be promising binding moieties to trigger intern...

Full description

Bibliographic Details
Main Authors: Lisa Bartmann, David Schumacher, Saskia von Stillfried, Marieke Sternkopf, Setareh Alampour-Rajabi, Marc A. M. J. van Zandvoort, Fabian Kiessling, Zhuojun Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Pharmacology
Subjects:
riboflavin
RFVT
theranostic
nanocarrier
cancer therapy
targeting molecules
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00079/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00079/full

Similar Items